Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges
Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. H...
Saved in:
| Main Authors: | Karan Seegobin, Bharatsinh Gharia, Satish Maharaj, Lara Zuberi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2018/2080185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Essential thrombocythemia: Busulphan revisited
by: Prasad R Koduri
Published: (2016-01-01) -
Cholinergic Pruritus as an Early Sign of Essential Thrombocythemia With Therapeutic Response to Ruxolitinib
by: L. Mateu-Arrom, et al.
Published: (2025-06-01) -
The Levels of Adhesion Molecules in Essential Thrombocythemia
by: Oktay Bilgir, et al.
Published: (2014-08-01) -
THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA
by: A. A. Zhernyakova, et al.
Published: (2017-06-01) -
Chilblains as a Clue for the Diagnosis of Essential Thrombocythemia
by: Hugo J. Leme, et al.
Published: (2025-05-01)